Curis
CRIS
#11024
Rank
ยฃ0.5 M
Marketcap
ยฃ0.26
Share price
-17.89%
Change (1 day)
-80.81%
Change (1 year)

P/S ratio for Curis (CRIS)

P/S ratio as of July 2026 (TTM): 0.0956

According to Curis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0532. At the end of 2026 the company had a P/S ratio of 3.14.

P/S ratio history for Curis from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.14133.63%
20251.35-46.65%
20242.52-66.35%
20237.5043.71%
20225.22-87.26%
202140.9-38.66%
202066.81081.79%
20195.65157.53%
20182.19-81.09%
201711.6-79.84%
201657.520.72%
201547.6263.4%
201413.1-18.77%
201316.1-0.2%
201216.2-33.39%
201124.3155.42%
20109.50-62.68%
200925.5347.65%
20085.6950.44%
20073.78-9.14%
20064.16-73.01%
200515.4-69.21%
200450.1203.15%
200316.5829.16%
20021.78-98.93%
2001167

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.21 2,209.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.62 2,634.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
8.22 8,491.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
5.86 6,025.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
> 1000 3,343,393.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.5800 506.49%๐Ÿ‡บ๐Ÿ‡ธ USA